Gemphire Therapeutics
Why Robinhood?
You can watch GEMP and buy or sell other stocks, ETFs, and their options commission-free!About GEMP
Gemphire Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of therapeutics of dyslipidemia, as well as non-alcoholic fatty liver disease. It offers a small molecule formulated as a tablet product under the Gemcabene brand.
GEMP Key Statistics
Stock Snapshot
Gemphire Therapeutics(GEMP) stock is priced at $8.18, giving the company a market capitalization of 18.01M. It carries a P/E multiple of -0.10.
On 2026-03-09, Gemphire Therapeutics(GEMP) stock opened at —, reached a high of —, and a low of —.
The Gemphire Therapeutics(GEMP)'s current trading volume is 0, compared to an average daily volume of 121.5K.
In the last year, Gemphire Therapeutics(GEMP) shares hit a 52-week high of $23.10 and a 52-week low of $1.34.
In the last year, Gemphire Therapeutics(GEMP) shares hit a 52-week high of $23.10 and a 52-week low of $1.34.
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.